Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fampridine-SR for Spasticity in Spinal Cord Injury
NCT00041717Phase 3Completed
- Sponsor
- Acorda Therapeutics
- Start
- Jul 2002
- Primary completion
- Feb 2004
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 3 trial of dalfampridine in Spasticity, sponsored by Acorda Therapeutics. Started Jul 2002; status: completed.
02
Drugs
dalfampridine
03
Conditions
Spasticity
Beyond the preview
Go deeper on NCT00041717.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00041717.